Lorazepam for the Analgosedation of Pediatric Patients in Mechanical Ventilation.
Status:
Not yet recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to better define the pharmacokinetic and pharmacodynamic profile of
lorazepam for the analgosedation in pediatric intensive care unit. This will help to better
define the dosages and administration modalities (bolus or continue infusion) required to
achieve analgosedation with lorazepam in pediatric patients undergoing mechanical
ventilation.
Phase:
Phase 2
Details
Lead Sponsor:
Bambino Gesù Hospital and Research Institute
Collaborators:
Ministero della Salute, Italy University College, London